References
- HoMLiuDTLamDSJonasJBRetinal vein occlusions, from basics to the latest treatmentRetina201636343244826716954
- WongTYScottIUClinical practice. Retinal-vein occlusionN Engl J Med2010363222135214421105795
- KleinRKleinBEMossSEMeuerSMThe epidemiology of retinal vein occlusion: the Beaver Dam Eye StudyTrans Am Ophthalmol Soc20009813314111190017
- KleinRMossSEMeuerSMKleinBEThe 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye StudyArch Ophthalmol2008126451351818413521
- RogersSMcIntoshRLCheungNInternational Eye Disease ConsortiumThe prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and AustraliaOphthalmology2010117231331920022117
- PielenAFeltgenNIsserstedtCCallizoJJunkerBSchmuckerCEfficacy and safety of intravitreal therapy in macular edema due to branch and central retinal vein occlusion: a systematic reviewPLoS One2013810e7853824205253
- DeisslerHLLangGKLangGECapacity of aflibercept to counteract VEGF-stimulated abnormal behavior of retinal microvascular endothelial cellsExp Eye Res2014122203124631334
- PapadopoulosNMartinJRuanQBinding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumabAngiogenesis201215217118522302382
- BoyerDHeierJBrownDMVascular endothelial growth factor Trap-Eye for macular edema secondary to central retinal vein occlusion: six-month results of the phase 3 COPERNICUS studyOphthalmology201211951024103222440275
- BrownDMHeierJSClarkWLIntravitreal aflibercept injection for macular edema secondary to central retinal vein occlusion: 1-year results from the phase 3 COPERNICUS studyAm J Ophthalmol2013155342943723218699
- HeierJSClarkWLBoyerDSIntravitreal aflibercept injection for macular edema due to central retinal vein occlusion: two-year results from the COPERNICUS studyOphthalmology201412171414142024679444
- HolzFGRoiderJOguraYVEGF Trap-Eye for macular oedema secondary to central retinal vein occlusion: 6-month results of the phase III GALILEO studyBr J Ophthalmol201397327828423298885
- KorobelnikJFHolzFGRoiderJIntravitreal aflibercept injection for macular edema resulting from central retinal vein occlusion: one-year results of the phase 3 GALILEO studyOphthalmology2014121120220824084497
- OguraYRoiderJKorobelnikJFGALILEO Study GroupIntravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase 3 GALILEO studyAm J Ophthalmol201415851032103825068637
- YehWSHallerJALanzettaPEffect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implantOphthalmology201211961190119822361318
- CampochiaroPABrownDMAwhCCSustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III studyOphthalmology2011118102041204921715011